134 related articles for article (PubMed ID: 4045996)
1. Natural killing (NK) potential of cord blood lymphocytes.
Toder V; Durdana A; Elrad H; Gleicher N
J Clin Lab Immunol; 1985 May; 17(1):29-32. PubMed ID: 4045996
[TBL] [Abstract][Full Text] [Related]
2. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
Seki H; Ueno Y; Taga K; Matsuda A; Miyawaki T; Taniguchi N
J Immunol; 1985 Oct; 135(4):2351-6. PubMed ID: 3928745
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte subpopulations in the neonate: high percentage of circulating B73.1+, HNK-1- cells.
Montagna D; Ferremi P; Alberini C; Porta FA; de Amici M; Astaldi-Ricotti GC; Maccario R; Ugazio AG
Thymus; 1986; 8(3):171-6. PubMed ID: 3750384
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of diminished natural killer cell activity in pregnant women and neonates.
Baley JE; Schacter BZ
J Immunol; 1985 May; 134(5):3042-8. PubMed ID: 3980989
[TBL] [Abstract][Full Text] [Related]
5. Natural cytotoxicity in the neonate: high levels of lymphokine activated killer (LAK) activity.
Montagna D; Maccario R; Ugazio AG; Mingrat G; Burgio GR
Clin Exp Immunol; 1988 Jan; 71(1):177-81. PubMed ID: 2964956
[TBL] [Abstract][Full Text] [Related]
6. Killing activity of human umbilical cord blood-derived TCRValpha24(+) NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells.
Hagihara M; Gansuvd B; Ueda Y; Tsuchiya T; Masui A; Tazume K; Inoue H; Kato S; Hotta T
Cancer Immunol Immunother; 2002 Mar; 51(1):1-8. PubMed ID: 11845254
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.
Balch CM; Tilden AB; Dougherty PA; Cloud GA; Abo T
Surgery; 1984 Jan; 95(1):63-70. PubMed ID: 6581546
[TBL] [Abstract][Full Text] [Related]
8. Characterization of HNK-1+ (Leu-7) human lymphocytes. II. Distinguishing phenotypic and functional properties of natural killer cells from activated NK-like cells.
Abo T; Balch CM
J Immunol; 1982 Oct; 129(4):1758-61. PubMed ID: 7108226
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell function of human neonatal lymphocytes.
Uksila J; Lassila O; Hirvonen T
Clin Exp Immunol; 1982 Jun; 48(3):649-54. PubMed ID: 6180853
[TBL] [Abstract][Full Text] [Related]
11. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR
Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
[TBL] [Abstract][Full Text] [Related]
13. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
Jezewska E; Björkholm M; Giscombe R; Holm G; Tullgren O
Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422
[TBL] [Abstract][Full Text] [Related]
14. The relationship of HNK-1 (Leu 7) and VEP13 antigens on human cells mediating natural killing.
Rumpold H; Kraft D; Gastl G; Huber C
Clin Exp Immunol; 1984 Sep; 57(3):703-9. PubMed ID: 6467685
[TBL] [Abstract][Full Text] [Related]
15. Studies of natural killer cells in pregnancy. I. Analysis at the single cell level.
Toder V; Nebel L; Gleicher N
J Clin Lab Immunol; 1984 Jul; 14(3):123-7. PubMed ID: 6207299
[TBL] [Abstract][Full Text] [Related]
16. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.
Perussia B; Starr S; Abraham S; Fanning V; Trinchieri G
J Immunol; 1983 May; 130(5):2133-41. PubMed ID: 6833758
[TBL] [Abstract][Full Text] [Related]
17. Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability.
Abo T; Cooper MD; Balch CM
J Immunol; 1982 Oct; 129(4):1752-7. PubMed ID: 6980948
[TBL] [Abstract][Full Text] [Related]
18. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
Condiotti R; Nagler A
Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
[TBL] [Abstract][Full Text] [Related]
20. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
